Font Size: a A A

Effects Of PVTT Type On Long-term Outcomes Of HCC Resection

Posted on:2015-03-06Degree:MasterType:Thesis
Country:ChinaCandidate:H P MengFull Text:PDF
GTID:2254330431955491Subject:Surgery
Abstract/Summary:PDF Full Text Request
Objectives In patients of HCC, up to12.9-39.7percents are complicated with portal vein tumor thrombosis(PVTT). PVTT is a key factor for poor prognosis,which can lead to intrahepatic metastasis and portal hypertension. Scholars have tried various treatments in an attempt to improve short-term prognosis, but so far no standard protocol is reached. There is still lack of consensus on surgical treatment of HCC complicated with PVTT as to its indications, contradictions and long-term prognosis. We carried out a retrospective study of preoperative, intraoperative and postoperative data of patients of different types of PVTT in order to explore the effects of PVTT on long-term outcomes of HCC resection and analyzed prognostic factors.Materials and methods Retrospectively analyze the203patients who underwent hepatic resection with or without portal thrombectomy for HCC with PVTT at Qilu hospital of Shandong University during January2010to December2012. According to the classification of Liver Cancer Study Group of Japan, PVTT are divied into four types:VP1(PVTT locates distal to the second branch of portal vein), VP2(PVTT invades the second branch of portal vein), VP3(PVTT invades the first branch of portal vein), VP4(PVTT invades the main portal trunk or first branches of both sides). Analyze the clinical characteristics, occurrence and survival rates. SPSS18.0statistical software package was used, P (0.05is statistically significant.Results According to the intraoperative data, as the type went from VP1to VP4, operation time and duration of vascular clamping were longer, median intraoperative blood loss and median perioperative blood transfusion were larger. According to the postoperative data, complication rate is30.0%. At a median follow up of6.5(2-59)months, the1-and3-year overall survival rates were33.5%and12.8%respectively, the1-and3-year disease-free survival rates were10.8%and3.0%. The overall survival rate of VP4patients was significantly lower than those of VP1,VP2and VP3patients (P<0.01), the differences of overall survival rates among VP1,VP2and VP3patients are statistically significant. Also, the disease-free survival rate of VP4patients was significantly lower than those of VP1,VP2and VP3patients (P <0.01), the differences of disease-free survival rates among VP1,VP2and VP3patients are statistically significant.Using univariate analysis, factors correlate negatively with survival are VP4type, positivity of HBsAg, AFP〉20ng/mL and tumor diameter〉5cm. On multivariate analysis, PVTT typing, AFP〉20ng/mL and tumor diameter〉5cm are independent predictors of poor survival.Conlusions For HCC with PVTT, long-term outcome of surgical treatment is directly related with PVTT typing. VP4pantients has a much worse prognosis and much more operation risk than patients of the other three types. We advocate a relatively aggressive approach when it comes to patients of the other three types, as they have relatively high survival rates and low complication rates, whereas take a prudent aproach towards VP4patients.
Keywords/Search Tags:Hepatocellular carcinoma, Portal vein tumor thrombosis, Portal vein, Surgical treatment
PDF Full Text Request
Related items
Evaluation Of The Efficacy And Safety Portal Vein Stent Combined With Iodine-125 Seed Implantationa Or Radiofrequency Ablation In The Treatment Of Hepatocellular Carcinoma With Portal Vein Thrombosis
Experiments And Clinical Application Study Of Interventional Treatment Of Portal Vein System Thrombosis
Relevant Factor Of Portal Vein Thrombosis In Patients After Splenectomy And Portal-azygous Devascularization For Portal Hypertensive Patient
Comparison Of Surgical Resection Versus Transarterial Chemoembolization In Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombosis
Survival Prognosis Of Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombus After Adjuvant Hepatic Transcatheter Arterial Chemoembolization Combined With Portal Vein Chemotherapy
Efficacy Evaluation Of FOLFOX4 Chemotherapy With Portal Vein Infusion In Patients With Hepatocellular Carcinoma Complicated With Portal Vein Thrombus After Tumor Resection
Evaluation Of The Clinical Utility Of TACE Combined With Sorafenib In The Treatment Of Primary Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Curative Analysis Of Several Therapeutic Methods For Hepatocellular Carcinoma With Tumor Thombosis In Portal Vein (Following 85 Cases)
The Study Of Radiosensitivity On Portal Vein Tumor Thrombus For Hepatocellular Carcinoma
10 Retrospective Study Of Clinical Efficacy Of TACE Combined With Endovascular Treatment Of Portal Vein Of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus